News

FreeSlate claimed that it provides researchers with increased experimental capacity and faster decision-making via its microscale, high-throughput technology, lab execution and analysis software, and experienced engineers and application

PharPoint plans to utilise Medrio’s technology in all phases of clinical drug development from Phase I – IIIb studies as well as post marketing studies, registries and outcomes

According to Neil Ferguson, vice-president of finance with Stirling Products in Charlottetown, Stirling Products of Australia will have control over both the North Sydney plant and the Charlottetown

UK-based BP is a manufacturer of self adhesive labels for the pharmaceutical, healthcare, cosmetic and food & drink markets, often providing them as part of an authentication solution.

The study, Horizon III, assessed the efficacy of Cediranib compared with Bevacizumab, both in combination with chemotherapy. Clinical activity was observed in the Cediranib arm of the study

Reportedly, the collaboration spans a range of research projects. Thomas Jensen, founder and CEO of Intomics, said: “We are extremely pleased to be working with LEO Pharma on

Cros NT said that Estimate, which has expertise and a particular excellence concerning the oncology and dermatology-related research, would enrich it. Estimate, found in 1992, is a privately

The studies were presented at the American Society of Clinical Oncology’s (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco. In the two studies, PCA3 was used to test

The goal of the research collaboration is to demonstrate whether genomic sequencing of cancer tissue can provide clues for treatment strategies for these individuals. The research study brings